Memorial Sloan-Kettering Cancer Center (MSKCC/Motzer) Score for Metastatic Renal Cell Carcinoma (RCC)
Predicts survival based on clinical and laboratory data in metastatic RCC patients.
INSTRUCTIONS
-
Use baseline factors at the start date of the current line of systemic therapy, except for the “time of diagnosis to systemic therapy” criterion, which is always relative to first-line therapy.
-
Always correct calcium concentration for low albumin before scoring.
When to Use
Pearls/Pitfalls
Why Use
No
0Yes
+1No
0Yes
+1No
0Yes
+1No
0Yes
+1No
0Yes
+1Result:
Please fill out required fields.